<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000554'>Uveitis</z:hpo> is defined as an intraocular <z:mp ids='MP_0001845'>inflammation</z:mp> induced by different etiologies </plain></SENT>
<SENT sid="1" pm="."><plain>Though the precise pathogenesis is still unknown, accumulating evidence shows that both innate and adaptive immune responses may be predominant mechanisms involved in the development of <z:hpo ids='HP_0000554'>uveitis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Toll-like receptors have been shown to be expressed in the human eye and play an important role in infectious <z:hpo ids='HP_0000554'>uveitis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOD</z:e> proteins, expressed mainly in the cytosol by APCs, recognize the products of bacteria and participate in the development of <z:hpo ids='HP_0000554'>uveitis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>HLA genes have been associated with some <z:hpo ids='HP_0000554'>uveitis</z:hpo> entities, including <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0012122'>anterior uveitis</z:hpo> (HLA-B27), <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet disease</z:e> (HLA-B51), <z:e sem="disease" ids="C0339402" disease_type="Disease or Syndrome" abbrv="">birdshot retinochoroidopathy</z:e> (HLA-A29), <z:e sem="disease" ids="C0042170" disease_type="Disease or Syndrome" abbrv="">Vogt-Koyanagi-Harada syndrome</z:e> (HLA-DR4), <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e>, <z:e sem="disease" ids="C0029077" disease_type="Disease or Syndrome" abbrv="">sympathetic ophthalmia</z:e>, juvenile idiopathic <z:hpo ids='HP_0001369'>arthritis</z:hpo>, <z:hpo ids='HP_0001970'>tubulointerstitial nephritis</z:hpo> and <z:hpo ids='HP_0000554'>uveitis</z:hpo> (TINU) syndrome, and <z:e sem="disease" ids="C0030593" disease_type="Disease or Syndrome" abbrv="">pars planitis</z:e> (HLA-DR15) </plain></SENT>
<SENT sid="5" pm="."><plain>The exact mechanism whereby certain HLA genes predispose to a certain <z:hpo ids='HP_0000554'>uveitis</z:hpo> entity has not yet been elucidated </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, several studies have demonstrate that polymorphisms in certain immune response genes, such as <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF), MHC class I <z:chebi fb="1" ids="15841">polypeptide</z:chebi>-related sequence A (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MICA</z:e>), interleukin-1 (IL-1), and some chemokines, may contribute to the development of human <z:hpo ids='HP_0000554'>uveitis</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Polymorphisms in the gene coding for the costimulatory molecule known as cytotoxic T-lymphocyte antigen 4 (CTLA-4) were recently found in Chinese patients with <z:e sem="disease" ids="C0042170" disease_type="Disease or Syndrome" abbrv="">VKH syndrome</z:e> but not in patients with <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet disease</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Further developments in the unraveling of immune response genes may lead to a better understanding of human <z:hpo ids='HP_0000554'>uveitis</z:hpo> and will hopefully allow the development of novel treatment regimes </plain></SENT>
</text></document>